Search research articles
Contact Us
Filters
Showing results (591-600 of 643) with videos related to
Page
of 65
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 17, 2020
Molecular Landscape of BRAF-Mutant NSCLC Reveals an Association Between Clonality and Driver Mutations and Identifies Targetable Non-V600 Driver Mutations
Marcelo V Negrao, Victoria M Raymond, Richard B Lanman, et al.
The Oncologist
|
March 14, 2026
Telemedicine as a Gateway to Early-Phase Oncology Trials: Lessons from 14,000 Patients and Future Directions for Global Access and Equity
Carlos Torrado, Clark R Andersen, Lei Kang, et al.
NPJ Precision Oncology
|
January 4, 2025
Cyclin E1/CDK2 activation defines a key vulnerability to WEE1 kinase inhibition in gynecological cancers
Daehwan Kim, Heekyung Chung, Wen Liu, et al.
Oncotarget
|
September 3, 2015
BRAF mutation testing with a rapid, fully integrated molecular diagnostics system
Filip Janku, Bart Claes, Helen J Huang, et al.
Molecular Cancer Therapeutics
|
May 22, 2016
BRAF Mutation Testing in Cell-Free DNA from the Plasma of Patients with Advanced Cancers Using a Rapid, Automated Molecular Diagnostics System
Filip Janku, Helen J Huang, Bart Claes, et al.
Cancer Research
|
September 14, 2021
Oxidative Phosphorylation Is a Metabolic Vulnerability in Chemotherapy-Resistant Triple-Negative Breast Cancer
Kurt W Evans, Erkan Yuca, Stephen S Scott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 27, 2021
Differential Outcomes in Codon 12/13 and Codon 61 <i>NRAS</i>-Mutated Cancers in the Phase II NCI-MATCH Trial of Binimetinib in Patients with <i>NRAS</i>-Mutated Tumors
James M Cleary, Victoria Wang, Rebecca S Heist, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 2, 2023
The New NCI Precision Medicine Trials
Lyndsay N Harris, Charles D Blanke, Harry P Erba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 2019
Molecular Profiling of Hepatocellular Carcinoma Using Circulating Cell-Free DNA
Ahmed O Kaseb, Nora S Sánchez, Shiraj Sen, et al.
Nature Communications
|
February 6, 2023
Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers
James J Harding, Sarina A Piha-Paul, Ronak H Shah, et al.
Page
of 65
Search research articles
Search
Showing results (591-600 of 643) with videos related to
Sort By:
Page
of 65
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 17, 2020
Molecular Landscape of BRAF-Mutant NSCLC Reveals an Association Between Clonality and Driver Mutations and Identifies Targetable Non-V600 Driver Mutations
Marcelo V Negrao, Victoria M Raymond, Richard B Lanman, et al.
The Oncologist
|
March 14, 2026
Telemedicine as a Gateway to Early-Phase Oncology Trials: Lessons from 14,000 Patients and Future Directions for Global Access and Equity
Carlos Torrado, Clark R Andersen, Lei Kang, et al.
NPJ Precision Oncology
|
January 4, 2025
Cyclin E1/CDK2 activation defines a key vulnerability to WEE1 kinase inhibition in gynecological cancers
Daehwan Kim, Heekyung Chung, Wen Liu, et al.
Oncotarget
|
September 3, 2015
BRAF mutation testing with a rapid, fully integrated molecular diagnostics system
Filip Janku, Bart Claes, Helen J Huang, et al.
Molecular Cancer Therapeutics
|
May 22, 2016
BRAF Mutation Testing in Cell-Free DNA from the Plasma of Patients with Advanced Cancers Using a Rapid, Automated Molecular Diagnostics System
Filip Janku, Helen J Huang, Bart Claes, et al.
Cancer Research
|
September 14, 2021
Oxidative Phosphorylation Is a Metabolic Vulnerability in Chemotherapy-Resistant Triple-Negative Breast Cancer
Kurt W Evans, Erkan Yuca, Stephen S Scott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 27, 2021
Differential Outcomes in Codon 12/13 and Codon 61 <i>NRAS</i>-Mutated Cancers in the Phase II NCI-MATCH Trial of Binimetinib in Patients with <i>NRAS</i>-Mutated Tumors
James M Cleary, Victoria Wang, Rebecca S Heist, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 2, 2023
The New NCI Precision Medicine Trials
Lyndsay N Harris, Charles D Blanke, Harry P Erba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 2019
Molecular Profiling of Hepatocellular Carcinoma Using Circulating Cell-Free DNA
Ahmed O Kaseb, Nora S Sánchez, Shiraj Sen, et al.
Nature Communications
|
February 6, 2023
Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers
James J Harding, Sarina A Piha-Paul, Ronak H Shah, et al.
Page
of 65